Tower Research Capital LLC (Trc) Bio Techne Corp Transaction History

Tower Research Capital LLC (Trc)

  • $4.87 Billion
  • Q4 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Bio Techne Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 10,823 shares of TECH stock, worth $680,009. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,823
Previous 3,694 192.99%
Holding current value
$680,009
Previous $295,000 164.07%
% of portfolio
0.02%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$66.37 - $78.17 $473,151 - $557,273
7,129 Added 192.99%
10,823 $779,000
Q3 2024

Nov 14, 2024
SELL
$70.96 - $82.35 $1.13 Million - $1.31 Million
-15,940 Reduced 81.19%
3,694 $295,000
Q2 2024

Aug 13, 2024
BUY
$62.12 - $84.15 $939,068 - $1.27 Million
15,117 Added 334.67%
19,634 $1.41 Million
Q1 2024

May 15, 2024
SELL
$65.98 - $77.09 $1.84 Million - $2.15 Million
-27,861 Reduced 86.05%
4,517 $317,000
Q4 2023

Feb 13, 2024
BUY
$52.83 - $78.22 $1.03 Million - $1.53 Million
19,530 Added 152.01%
32,378 $2.5 Million
Q3 2023

Nov 14, 2023
BUY
$67.52 - $89.42 $215,928 - $285,965
3,198 Added 33.14%
12,848 $874,000
Q2 2023

Aug 14, 2023
BUY
$73.76 - $85.98 $244,588 - $285,109
3,316 Added 52.35%
9,650 $787,000
Q1 2023

May 09, 2023
BUY
$71.62 - $86.62 $244,725 - $295,980
3,417 Added 117.14%
6,334 $469,000
Q4 2022

Feb 10, 2023
SELL
$80.67 - $352.29 $98,417 - $429,793
-1,220 Reduced 29.49%
2,917 $242,000
Q3 2022

Nov 10, 2022
SELL
$282.54 - $391.85 $604,635 - $838,559
-2,140 Reduced 34.09%
4,137 $1.18 Million
Q2 2022

Aug 15, 2022
SELL
$322.67 - $449.65 $168,111 - $234,267
-521 Reduced 7.66%
6,277 $2.18 Million
Q1 2022

May 12, 2022
BUY
$353.85 - $487.79 $1.75 Million - $2.41 Million
4,949 Added 267.66%
6,798 $2.94 Million
Q4 2021

Feb 14, 2022
BUY
$456.15 - $525.06 $299,234 - $344,439
656 Added 54.99%
1,849 $956,000
Q3 2021

Nov 15, 2021
SELL
$444.87 - $538.88 $2.17 Million - $2.63 Million
-4,877 Reduced 80.35%
1,193 $578,000
Q2 2021

Aug 16, 2021
BUY
$387.35 - $450.26 $1.88 Million - $2.19 Million
4,859 Added 401.24%
6,070 $2.73 Million
Q1 2021

May 17, 2021
SELL
$314.62 - $411.0 $274,034 - $357,981
-871 Reduced 41.83%
1,211 $463,000
Q4 2020

Feb 16, 2021
SELL
$246.9 - $321.87 $53,330 - $69,523
-216 Reduced 9.4%
2,082 $661,000
Q3 2020

Nov 16, 2020
SELL
$232.22 - $282.96 $1.71 Million - $2.09 Million
-7,371 Reduced 76.23%
2,298 $569,000
Q2 2020

Aug 13, 2020
BUY
$185.43 - $279.56 $1.57 Million - $2.37 Million
8,462 Added 701.08%
9,669 $2.55 Million
Q1 2020

May 15, 2020
SELL
$161.17 - $221.51 $113,463 - $155,943
-704 Reduced 36.84%
1,207 $229,000
Q4 2019

Feb 07, 2020
BUY
$189.68 - $222.09 $147,760 - $173,008
779 Added 68.82%
1,911 $419,000
Q3 2019

Nov 05, 2019
SELL
$183.56 - $216.72 $140,239 - $165,574
-764 Reduced 40.3%
1,132 $222,000
Q2 2019

Aug 13, 2019
BUY
$188.72 - $215.43 $96,813 - $110,515
513 Added 37.09%
1,896 $395,000
Q1 2019

May 14, 2019
BUY
$136.09 - $200.44 $165,485 - $243,735
1,216 Added 728.14%
1,383 $275,000
Q4 2018

Feb 14, 2019
SELL
$132.75 - $203.8 $603,216 - $926,067
-4,544 Reduced 96.46%
167 $24,000
Q3 2018

Nov 13, 2018
BUY
$147.44 - $204.11 $163,216 - $225,949
1,107 Added 30.72%
4,711 $962,000
Q2 2018

Aug 15, 2018
BUY
$144.9 - $165.58 $43,325 - $49,508
299 Added 9.05%
3,604 $533,000
Q1 2018

May 15, 2018
BUY
$131.46 - $151.04 $381,234 - $438,016
2,900 Added 716.05%
3,305 $499,000
Q4 2017

Feb 09, 2018
BUY
$121.17 - $134.75 $26,415 - $29,375
218 Added 116.58%
405 $53,000
Q3 2017

Nov 14, 2017
BUY
$113.59 - $123.78 $21,241 - $23,146
187
187 $23,000

Others Institutions Holding TECH

# of Institutions
618
Shares Held
156M
Call Options Held
161K
Put Options Held
12.7K
View Full List

About BIO-TECHNE Corp

TECH Quotes by TradingView
  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.46B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email